Eone Diagnomics (Korea) Today
Eone Diagnomics is trading at 415.00 as of the 26th of April 2024, a -3.94 percent down since the beginning of the trading day. The stock's open price was 432.0. Equity ratings for Eone Diagnomics Genome are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of March 2024 and ending today, the 26th of April 2024. Click here to learn more.
Eone Diagnomics Genome cannot be verified against its exchange. It appears Eone Diagnomics is not available for investing at the moment. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshEone Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Eone Diagnomics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Eone Diagnomics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals (View all Sectors) |
Eone Diagnomics Genome (245620) is traded on KOSDAQ in Korea and employs 100 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 68.84 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eone Diagnomics's market, we take the total number of its shares issued and multiply it by Eone Diagnomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Eone Diagnomics Genome has 36.17 M outstanding shares.
Eone Diagnomics Genome has accumulated about 27.54 B in cash with (1.73 B) of positive cash flow from operations.
Check Eone Diagnomics Probability Of Bankruptcy
Eone Stock Against Markets
Picking the right benchmark for Eone Diagnomics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Eone Diagnomics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Eone Diagnomics is critical whether you are bullish or bearish towards Eone Diagnomics Genome at a given time. Please also check how Eone Diagnomics' historical prices are related to one of the top price index indicators.
Try Other Suggestions
| 21039CAA2 | Constellium 5625 percent | Corporate Bond |
Eone Diagnomics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eone Diagnomics stock to make a market-neutral strategy. Peer analysis of Eone Diagnomics could also be used in its relative valuation, which is a method of valuing Eone Diagnomics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
How to buy Eone Stock?
Before investing in Eone Diagnomics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Eone Diagnomics. To buy Eone Diagnomics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Eone Diagnomics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Eone Diagnomics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Eone Diagnomics Genome stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Eone Diagnomics Genome stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Eone Diagnomics Genome, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Eone Diagnomics Genome?
The danger of trading Eone Diagnomics Genome is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Eone Diagnomics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Eone Diagnomics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Eone Diagnomics Genome is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Eone Diagnomics Genome information on this page should be used as a complementary analysis to other Eone Diagnomics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Eone Stock analysis
When running Eone Diagnomics' price analysis, check to measure Eone Diagnomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eone Diagnomics is operating at the current time. Most of Eone Diagnomics' value examination focuses on studying past and present price action to predict the probability of Eone Diagnomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eone Diagnomics' price. Additionally, you may evaluate how the addition of Eone Diagnomics to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |